Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04948866 · ClinicalTrials.gov registry record · NA
Palliative Care for Persons With Late-stage Alzheimer's and Related Dementias and Their Caregivers
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 884
- Enrollment target
NCT04948866 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 884 participants.
The verdict
NCT04948866, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 884 participants
- Enrollment target
Study Summary
Millions of Americans have late-stage Alzheimer's and related dementias (ADRD), causing suffering due to loss of awareness of self and family, progressive dependency, physical and neuropsychiatric symptoms, and physical, emotional and financial strain for caregivers. Investigators now propose a multi-site randomized clinical trial of the ADRD Palliative Care (ADRD-PC) program for persons with late-stage ADRD and their family caregivers, triggered during hospitalization. Investigators aim to learn if this program of dementia-specific palliative care, standardized caregiver education, and transitional care is effective to reduce burdensome hospital transfers, improve symptom treatment and control, augment supportive services, and reduce nursing home transitions for patients, and to improve caregiver outcomes of communication, shared decision-making and distress.
Interventions
- BEHAVIORAL ADRD-PC Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 884 participants |
| Start Date | 2021-07-26 |
| Est. Completion | 2025-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04948866
The ClinicalTrials.gov registry entry for NCT04948866 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 884 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ADRD-PC Program is the first listed.
NCT04948866 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04948866 about?
NCT04948866 is a clinical study titled "Palliative Care for Persons With Late-stage Alzheimer's and Related Dementias and Their Caregivers". Millions of Americans have late-stage Alzheimer's and related dementias (ADRD), causing suffering due to loss of awareness of self and family, progressive dependency, physical and neuropsychiatric symptoms, and physical, emotional and financial strain for caregivers. Investigators now propose a mult...
What is the current status of trial NCT04948866?
This trial is currently completed. It is a NA study. The enrollment target is 884 participants. The study started on 2021-07-26. Estimated completion is 2025-02-01.
What interventions are being tested in trial NCT04948866?
The interventions under investigation include: ADRD-PC Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04948866?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.